Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 23
Phase 42

Trial Status

Completed2
Recruiting4
Other5

Role Distribution

Principal Investigator10
Other Roles1
PI Rate91%

Activity Timeline

Clinical Trials (11)

NCT07281014Phase 4Active Not Recruiting
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Heart Failure
PrincipalinvestigatorStart date: 2026-01-27
NCT06872645Not ApplicableRecruiting
Exploring Water-free Sodium Storage
Peritoneal Dialysis, Heart Failure
PrincipalinvestigatorStart date: 2025-10-03
NCT06815471Phase 2Suspended
CRF2 Agonist for the Treatment of Worsening Heart Failure
Worsening Heart Failure
StudychairStart date: 2025-08-07
NCT06209359Phase 1Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Diuretic ResistanceHeart Failure
PrincipalinvestigatorStart date: 2024-07-24
NCT05726032Phase 2Recruiting
Empagliflozin in Patients With Cirrhosis and Ascites
CirrhosisLiver Failure
PrincipalinvestigatorStart date: 2023-09-11
NCT05553938Phase 1Active Not Recruiting
Effects of Acute and Chronic Empagliflozin Heart Failure
Heart Failure
PrincipalinvestigatorStart date: 2023-08-04
NCT05671991Phase 4Active Not Recruiting
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
End Stage Renal Disease on Dialysis
PrincipalinvestigatorStart date: 2023-03-01
NCT04438213Phase 2Recruiting
Ertugliflozin in Chronic Heart Failure
Heart Failure
PrincipalinvestigatorStart date: 2021-03-10
NCT03027960Phase 1Completed
Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
Heart FailureType II; Diabetes
PrincipalinvestigatorStart date: 2017-06-27
NCT02546583Phase 1Completed
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
Heart Failure
PrincipalinvestigatorStart date: 2015-08-31

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT07281014Phase 4PrincipalInvestigator

Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing

Heart Failure
Active Not Recruiting
NCT06872645Not ApplicablePrincipalInvestigator

Exploring Water-free Sodium Storage

Peritoneal Dialysis, Heart Failure
Recruiting
NCT06815471Phase 2StudyChair

CRF2 Agonist for the Treatment of Worsening Heart Failure

Worsening Heart Failure
Suspended
NCT06209359Phase 1PrincipalInvestigator

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Diuretic ResistanceHeart Failure
Recruiting
NCT05726032Phase 2PrincipalInvestigator

Empagliflozin in Patients With Cirrhosis and Ascites

CirrhosisLiver Failure
Recruiting
NCT05553938Phase 1PrincipalInvestigator

Effects of Acute and Chronic Empagliflozin Heart Failure

Heart Failure
Active Not Recruiting
NCT05671991Phase 4PrincipalInvestigator

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

End Stage Renal Disease on Dialysis
Active Not Recruiting
NCT04438213Phase 2PrincipalInvestigator

Ertugliflozin in Chronic Heart Failure

Heart Failure
Recruiting
NCT03027960Phase 1PrincipalInvestigator

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

Heart FailureType II; Diabetes
Completed
NCT02546583Phase 1PrincipalInvestigator

Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure

Heart Failure
Completed
NCT03093090Phase 1PrincipalInvestigator

Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide

Medication Absorption
Withdrawn

All 11 trials loaded